MyD88 Contributes to TLR3-Mediated NF-κB Activation and Cytokine Production in Macrophages
Cells · 2025
DOI: 10.3390/cells14191507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Zhuodong Chai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX 77845, USA. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Myeloid Differentiation Factor 88, Macrophages, NF-kappa B. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Toll-like receptor 3 (TLR3) initiates antiviral and inflammatory responses exclusively through the adaptor protein TRIF (TIR-domain-containing adapter-inducing interferon-β). In contrast, MyD88 (myeloid differentiation primary response 88), a central adaptor for most other TLRs, is traditionally considered dispensable for TLR3 signaling. Here, we demonstrate that MyD88 directly contributes to TLR3-mediated NF-κB activation and cytokine production in macrophages. Bone marrow-derived macrophages (BMDMs) from MyD88 deficient mice exhibited significantly attenuated NF-κB activation in response to the TLR3 agonist polyinosinic–polycytidylic acid (poly(I:C)) compared to wild-type cells, as evidenced by the reduced phosphorylation of NF-κB p65 and IκBα, as well as IκBα degradation. Consistently, pro-inflammatory cytokine production, including IL-6, TNF-α, and IFN-β, was attenuated in MyD88-deficient BMDMs in vitro following stimulation by poly(I:C) or poly(A:U), another TLR3 agonist. Blood concentrations of IL-6, TNF-α, and IFN-β were significantly reduced in both TRIF-deficient mice and MyD88-deficient mice challenged by the i.p. injection of poly(I:C). Mechanistic analyses revealed that MyD88 physically associates with activated TLR3 upon poly(I:C) stimulation, and that TLR3 engagement triggered MyD88 oligomerization, which was absent in TLR3 or TRIF deficient macrophages. Our findings highlight a previously unrecognized dual-adaptor mechanism for TLR3, wherein MyD88 recruitment amplifies NF-κB signaling dynamics by bridging TLR3 to the canonical NF-κB activation cascade and robust cytokine induction. This study expands the paradigm of TLR3 signaling by establishing MyD88 as a direct contributor to TLR3-driven innate immune responses, offering new insight into cross-talk between MyD88-dependent and -independent pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX 77845, USA.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- American Heart Association SouthWest Affiliate Postdoctoral Fellowship Award
- Texas A&M University Health Science Center Seedling Research Grants
Zitieren
APA
Chai, Z., Zhou, Y., Yang, L., Zhang, Y., Hossain, S., Hajimirzaei, S., Qi, J., Zhang, G., Wei, Y., & Li, Z. (2025). MyD88 Contributes to TLR3-Mediated NF-κB Activation and Cytokine Production in Macrophages. Cells. https://doi.org/10.3390/cells14191507
Vancouver
Chai Z, Zhou Y, Yang L, Zhang Y, Hossain S, Hajimirzaei S, et al. MyD88 Contributes to TLR3-Mediated NF-κB Activation and Cytokine Production in Macrophages. Cells. 2025. doi:10.3390/cells14191507
BibTeX
@article{Chai2025,
author = {Chai, Zhuodong and Zhou, Yuqi and Yang, Ling and Zhang, Yan and Hossain, Sukria and Hajimirzaei, Sahelosadat and Qi, Jiaqian and Zhang, Guoying and Wei, Yinan and Li, Zhenyu},
title = {MyD88 Contributes to TLR3-Mediated NF-κB Activation and Cytokine Production in Macrophages},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14191507}
}
EUVIMED